The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
45 GF Score
Price BDT316.70
GF Value BDT380.59
Valuation Modestly Undervalued
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Unearned Premiums?

Unearned Premiums only applies to insurance companies.

DHA:IBNSINA
45GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Overvalued in 2026?

Based on GuruFocus' analysis, The IBN SINA Pharmaceutical Industry stock appears to be undervalued. The current stock price of BDT316.70 is trading 16.8% below its estimated GF Value™ of BDT380.59. GuruFocus considers The IBN SINA Pharmaceutical Industry to be Modestly Undervalued.

Key valuation signals for DHA:IBNSINA:

  • Unearned Premiums:
  • GF Value™: BDT380.59 vs. price of BDT316.70 (16.8% below fair value)
  • GF Score™: 45/100

No single metric tells the full story. See the DHA:IBNSINA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
45GF Score

Get the complete analysis for DHA:IBNSINA

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT316.70
Price
BDT380.59
GF Value